fungal corneal ulcer · 2018-07-30 · • scrapings of corneal ulcers are obtained, from the most...
TRANSCRIPT
2018/7/31
FUNGAL CORNEAL ULCER
Arundhati Dvivedi final year p.g Dept.of Ophthalmology
Introduction:
• Fungal Keratitis is one of the most difficult forms of microbial keratitis to diagnose & to treat successfully
• Constitute 44% of all corneal ulcers in India • Fungi are eukaryotic, heterotrophic organisms & typically forms
reproductive spores.
• Fungus may be a part of normal external ocular flora. (3-28% of normal eyes)
CLASSIFICATION • Filamentous Septate Fungi (Non Pigmented): 1.Fusarium 2.Aspergillus
• Filamentous Septate Fungi(Pigmented): 1.Alternaria 2.Curvularia
• Filamentous Non Septate: 1.Mucor 2.Rhizopus • Yeasts: 1.Candida 2.Cryptococus
• Dimorphic fungi: 1.Histoplasma 2.Coccidioides and 3.Blastomyces
EPIDEMIOLOGY • Overall incidence is low- 6-20%
• Aspergillus most common organism worldwide.
• Incidence varies geographically: • Western countries: Candida, Aspergillus, Fusarium • In India: Aspergillus (27-64%) • Fusarium (6-32%) • Penicillium (2-29%) • Rural>urban • 21-50 years, males • Monsoon,early winter due to humidity & during harvest seasons • However, in colder climates, where Candida infections predominate
RISK FACTORS • OCULAR : • Trauma (M/C)-veg matter ,mud , animal matter – most common • Contact lens use: • Cosmetic Lens- filamentous • Therapeutic Lens- Yeast
• Indiscriminate use of Topical Medications- Corticosteroids and
Broad Spectrum Antibiotics
• Corneal Sx- Penetrating Keratoplasty, LASIK.
• Chronic Keratitis- Herpes Simplex, Herpes Zoster,Vernal/allergic keratitis
SYSTEMIC: Immunocompromised State- HIV, Leprosy Patients on immunosuppressives , Diabetes Mellitus , ICU patients
PATHOGENESIS • Fungi are saprophytic pathogenic organisms.
• Fungi gain entry into stroma through a defect in epithelial barrier.
release toxins and proteolytic enzymes
• Host response-PMNs at the site of defect from tears & limbal vessels
• Release of cytokines & interleukins
• Necrosis & sloughing of epithelium, Bowman’s membrane & stroma
• Progressive invasion of cornea & increase in size of ulcer • A saucer shaped defect with projecting walls above the normal
surface due to swelling of tissue resulting from fluid imbibition by corneal stroma with grey zone of infiltration
CLINICAL FEATURES
Symptoms: •Foreign body Sensation •Slow onset increasing pain •Watering •Photophobia •Clinical signs are more severe than symptoms. Signs: •Conjunctival injection •Epithelial defect •Anterior chamber reaction
2018/7/31
Specific: • Feathery edges with fluffy margins • Infiltrate • Elevated edges • Satellite lesions • Endothelial plaque • Grey/brown Pigmentation( s/o dermaticeous fungi like Curvularia) • Hypopyon ( non Sterile, thick & immobile) • Yellow line of demarcation • Immune Ring (Wesseley)
2018/7/31
Yeast: •A “collar button” configuration is typical of the keratitis associated with a small ulceration and an expanding discrete stromal infiltrate
•Confocal microscopy is rarely available, but may permit identification of organisms in vivo.
Evaluation • Visual acuity • Slit lamp examination • KOH mount • IOP measurement with tonopen • B scan • Culture and senitivity.
• Systemic investigations- 1. Blood sugar levels 2. Complete blood picture 3. Liver function tests 4. Renal function tests
• scrapings of corneal ulcers are obtained, from the most active regions.
• The eye is anesthetized with topical anesthetic
• A heat-sterilized platinum spatula or blade no.15 or 11,is used to firmly scrape the leading edges of the ulcer.
• Multiple areas of a large ulcer should be sampled. • care must be exercised not to precipitate perforation. • calcium alginate swab moistened with soy broth can be used.
• Scrapings should be placed on a slide for staining and directly applied to
culture media, such as plates and broth, to maximize the chance of recovery.
• Multiple C streaks should be used on agar plates, because it is often difficult to identify an organism recovered in culture as the offending pathogen, and growth outside of the C streak might indicate contamination.
KOH mount
• Potassium hydroxide (KOH) preparation is used for the rapid detection of fungal elements in clinical specimen
• KOH is a strong alkali. • When specimen is mixed with 20% w/v KOH, it softens, digests and
clears the tissues , surrounding the fungi so that the hyphae and conidia (spores) of fungi can be seen under microscope.
Procedure for KOH mount • The scrapings are placed directly onto a microscope slide and are
covered with 10% or 20% potassium hydroxide.
• The slide is left to stand until clear, normally between five and fifteen minutes, in order to dissolve cells and debris.
• To enhance clearing dimethyl sulfoxide can be added to the slide. To make the fungi easier to see lactophenol cotton blue stain can be added.
• The slide is gently heated to speed up the action of the KOH.
• Adding calcofluor-white stain to the slide will cause the fungi to become fluorescent, making them easier to identify under a fluorescent microscope.
• Place the slide under a microscope to read.
KOH mount
2018/7/31
2018/7/31
Stains: •Gram Stain •Giemsa Stain
•Gomorie Methenamine Silver •PAS Stain •lectins
Fluoroscent Microscopy:
•Acridine Orange •Calcoflour white
•Potassium Hydroxide Wet Mount (10-20%w/v)
2018/7/31
• Lactophenol cotton blue-for quick evaluation of fungi, stains chitin in the cell wall of fungi.
• PAS- stains polysaccharide in the cellwall of fungi.
• Gomori methenamine Silver nitrate outlines fungi in black due to silver precipitating on the fungal cell wall.
2018/7/31
• SDA with Chloramphenicol -inhibits bacterial growth
• Cycloheximide to inhibit saprophytic fungi and some yeasts(including C.neoformans)
• Cycloheximide will prevent the growth of opportunistic pathogens -Aspergillus
2018/7/31
• Culture Media • Blood Agar
• Chocolate Agar
• Sabouraud’s dextrose Agar
• Thioglycollate Broth
• Brain Heart Infusion Broth / Solid Media
• Positive culture expected in 90% cases, within 72 hrs in 83% cases
within 1 week in 97% cases
• Increasing Humidity of medium by placing inoculated agar plates in Plastic bags enhance fungal growth.
2018/7/31
Candida on SDA
2018/7/31
• Candida albicans grows rapidly in culture, reaching maturity in as little as three days. Colonies are cream coloured, raised, entire, smooth & butyrous.
2018/7/31
Newer Methods
•Electron Microscopy •Polymerase Chain Reaction
SCRAPING
•Advantage: •Provide initial debridement of organisms- reduce the fungal load •Improve penetration of drugs
•Methods: •Surgical Blade •26 gauge needle •Diamond tipped motorized burr •Diagnostic Superficial Keratectomy/Corneal Biopsy
2018/7/31
• Corneal biopsy: Done in Minor OT with Topical Anaesthesia
• 2-3 mm dermatologic trephine on anterior corneal stroma incorporating both clinically infected & adjacent clear cornea.(Avoiding Visual Axis)
• Anterior Chamber Tap:
• Hypopyon
• or Endothelial Plaque
COMPLICATIONS:
1. Scleritis 2. Impending perforation 3. Endophthalmitis 4. Glaucoma
TREATMENT
MEDICAL •Topical: •Natamycin5% •Amphotericin B 0.15% •Cycloplegics •Antibiotics •IOP lowering medication
• SYSTEMIC: • Fluconazole • Voriconazole
• SURGICAL 1. Debridement
2.Therapeutic Penetrating
Keratoplasty
3.Conjunctival Flap
4.Flap + Keratectomy
5.Flap + Penetrating Graft
6.Lamellar Graft
7.Cryotherapy ( In Kerato scleritis)
2018/7/31
Anti fungals
• POLYENES: • Amphotericin B, Natamycin • Binds to ergosterol in fungal cell membrane & cause the membrane to
become leaky.
• AZOLES: • Ketoconazole
• Fluconazole
• Voriconazole
• Inhibits CYP P450 14 a demethylase enzyme involved in conversion of
lanosterol to ergosterol
2018/7/31
• PYRIMIDINES:
• Flucytosine
• Causes Faulty RNA Synthesis & non competitive inhibitor of Thymidylate Synthesis
• ALLYLAMINES: Terbinafine
• Ergosterol Biosynthesis inhibitor
• ECHINOCANDINS: Cell wall Synthesis inhibition by D-glucan synthesis inhibition
• Capsofungin , Micafungin
2018/7/31
• Topical
• Natamycin 5% is Initial drug of choice.
• Topical Amphotericin B 0.15% added in c/o worsening , candida &
aspergillus
• oral or Topical Azole added in c/o Fusarium
• Indication for Systemic antifungals:( voriconazole 1st choice)
• Severe deep keratitis
• Scleritis
• Endophthalmitis
• Prophylactic t/t after Penetrating Keratoplasty for Fungal Keratitis
• Virulent Fungus
2018/7/31
• Topical : initially 5% Natamycin- hrly :day time n 2 hrly : night
:+ fluoroquinolones for 2⁰ bacterial infections. • Bd eye checkups under slitlamp
• Resolving -give Natamycin 2 hrly ->2 wks
• worsening -topical Amphotericin B 0.15%/fluconazole 2% is given.
• CandidiaI - Ampho B 0.15%/ fluconazole 0.3% 1st choice
• Echinocandins , Ampho: not effective against fusarium • Nata 5% = econazole1% = voriconazole0.5 μg/ml.
2018/7/31
• VORICONAZOLE- derived from Fluconazole
• wider spectrum of activity against Candida,
• Aspergillus
• and Fusarium • exerts its effect from inhibition of cytochrome P450 dependant 14
alpha sterol demethylase , an enzyme involved in the ergosterol biosynthetic pathway.
2018/7/31
Intracameral therapy
• In severe keratomycosis not responding to topical natamycin • It ensures adequate drug delivery into AC and avoid surgical
intervention in the acute stage of the disease.
• performed under strict aseptic conditions.
• If the infection involves the anterior capsule of the lens, care should be taken to avoid injury to the lens.
• 5 μg ampho B in 0.1 mL 5% dextrose through a paracentesis • Injections repeated in case of inadequate response
2018/7/31
• Length of treatment is based on clinical response of individual.
• If toxicity is suspected and if adequate t/t has been given for 4 - 6 weeks treatment should be discontinued & patient is observed for reccurence in follow up.
• Subconjunctival injections:
• reserved in cases of scleritis, severe keratitis , endophthalmitis
• Miconazole (preferred) as is least toxic and best toleratedx(5 to 10 mg of 10mg/ml )suspension
2018/7/31
• INTRACORNEAL THERAPY
• for non healing fungal corneal ulcers
• Amphotericin B injection 5-7.5 μg , given near to stromal site of growth.
• raise the local concentration of the antifungal agent enough to be effective in the eradication of the deep corneal infection
• total elimination
• repeated after 48 to 72 hours
2018/7/31
• SIGNS OF IMPROVEMENT
• Decreased pain
• Decreased size of infiltrate.
• Disappeared satellite lesions
• Rounding of feathery margins
• DURATION OF TREATMENT :4 -6 WKS only due to toxicity
2018/7/31
Synergism: •Amphotericin B & flucytosine •Natamycin & Ketoconazole
Antagonism:
•Amphotericin B & Imidazoles
Antibiotics with Antifungal Property:
•Chloramphenicol -fusarium, Aspergillus •Moxifloxacin & tobramycin - Fusarium •Chlorhexidine •Povidone Iodine.
2018/7/31
SURGICAL MANAGEMENT
• 1. Debridement
• 2.Therapeutic Penetrating Keratoplasty
• 3.Conjunctival Flap
• 4.Flap + Keratectomy
• 5.Flap + Penetrating Graft
• 6.Lamellar Graft
• 7.Cryotherapy ( In Keratoscleritis)
2018/7/31
• Debridement: Done every 24 - 48 hrs under topical anaesthesia
• Debulks necrotic material & organisms
• Enhances penetration of topical drugs
• Penetrating Keratoplasty Indication:
• Infectious process progress to limbus or sclera
• Failure of medical t/t
• Recurrence of infection
• To delay or prevent the need for corneal transplant with severe thinning or perforation is managed with TISSUE ADHESIVE(N -BUTYL CYANOACRYLATE)
• BANDAGE CONTACT LENS
2018/7/31
• Technique for Penetrating Keratoplasty :
• Size of trephination should leave 1- 1.5 mm clear zone of clinically uninvolved cornea to reduce residual fungus.
• Interrupted sutures with slight longer bites should be used to avoid cheese wiring
• Irrigation of Anterior chamber with antifungals
• Affected intraocular structures like iris, lens,& vitreous should be excised, the lens should be left untouched to prevent the spread of infection in the posterior segment
• The specimens -mcirobiology and pathology for culture and fixed section examination.
• If involvement of intraocular structures or endophthalmitis is suspected, an antifungal agents :amphotericin B (5μg/0.1ml) or miconazole (25μg/0.1ml)
2018/7/31
2018/7/31
2018/7/31
• Fungal hyphae usually lie parallel to the cornea to the corneal surface and lamellae.
• A vertical or perpendicular arrangement of fungal hyphae in the corneal stroma: increased virulence and in patients on topical corticosteroid therapy.
• Surgical instruments should be changed to sterile ones once infected tissue removed to avoid recontamination.
2018/7/31
• If endophthalmitis is suspected:
• Intraocular Antifungal injected at the time of keratoplasty. ( Preferably AmphotericinB)
• After Penetrating keratoplasty: • Topical antifungals continued to prevent recurrence.
• If pathology reports are negative for organism at edge of corneal
specimen STOP antifungals after 2 weeks and follow up patient for recurrence.
• If Pathology reports are positive t/t continued for 6 -8 weeks.
2018/7/31
PROGNOSIS: • Factors associated with Treatment Failure:
• Large ulcer size (greater than 14mm square) • Presence of Hypopyon
• Aspergillus as causative organism